Transient up-regulation of biglycan during skeletal muscle regeneration: Delayed fiber growth along with decorin increase in biglycan-deficient mice

Developmental Biology

Volumn 268, Issue 2, 2004, Pages 358-371

  Casar, Juan Carlos ^a   McKechnie, Beth A ^b   Fallon, Justin R ^b   Young, Marian F ^c   Brandan, Enrique ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b BROWN UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Biglycan; Decorin; Embryonic myosin; Proteoglycans; Skeletal muscle regeneration

Indexed keywords

BARIUM CHLORIDE; BIGLYCAN; DECORIN; LEUCINE; MATRIX PROTEIN; MYOD PROTEIN; MYOGENIN; MYOSIN; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; MALE; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE GROWTH; MUSCLE REGENERATION; MYOTUBE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; STEM CELL; UPREGULATION;

EID: 1942518315     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ydbio.2003.12.025     Document Type: Article

References (60)

1. Ameye L., Young M.F. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology. 12:2002;107R-116R.
2. Ameye L., Aria D., Jepsen K., Oldberg A., Xu T., Young M.F. Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J. 16:2002;673-680.
3. Andrade W., Brandan E. Isolation and characterization of rat skeletal muscle proteoglycan decorin and comparison with the human fibroblast decorin. Comp. Biochem. Physiol., B. 100:1991;565-570.
4. Bianco P., Fisher L.W., Young M.F., Termine J.D., Robey P.G. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J. Histochem. Cytochem. 38:1990;1549-1563.
5. Blau H., Grace K., Pavlath E.C., Hardeman C.-P.C., Silberstein L., Webster S.G., Miller S.C., Webster C. Plasticity of the differentiated state. Science. 230:1985;758-766.
6. Border W.A., Noble N.A., Yamamoto T., Harper J.R., Yamaguchi Y., Pierschbacher M.D., Ruoslahti E. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature. 360:1992;361-364.
7. Boudreau N., Bissell M.J. Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr. Opin. Cell Biol. 10:1998;640-646.
8. Bowe M.A., Mendis D.B., Fallon J.R. The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle. J. Cell Biol. 148:2000;801-810.
9. Brandan E., Inestrosa N.C. Isolation of the heparan sulfate proteoglycans from the extracellular matrix of rat skeletal muscle. J. Neurobiol. 18:1987;271-282.
10. Brandan E., Fuentes M.E., Andrade W. The proteoglycan decorin is synthetized and secreted by differentiated myotubes. Eur. J. Cell Biol. 55:1991;209-216.
11. Brandan E., Fuentes M.E., Andrade W. Decorin, a chondroitin/dermatan sulfate proteoglycan, is under neural control in rat skeletal muscle. J. Neurosci. Res. 32:1992;51-59.
12. Brandan E., Carey D.J., Larrain J., Melo F., Campos A. Synthesis and processing of glypican during differentiation of skeletal muscle cells. Eur. J. Cell Biol. 71:1996;171-176.
13. Buckingham M. Making muscle in mammals. Trends Genet. 8:1992;144-149.
14. Caceres S., Cuellar C., Casar J.C., Garrido J., Schaefer L., Kresse H., Brandan E. Synthesis of proteoglycans is augmented in dystrophic mdx mouse skeletal muscle. Eur. J. Cell Biol. 79:2000;173-181.
15. Caldwell C.J., Mattey D.L., Weller R.O. Role of the basement membrane in the regeneration of skeletal muscle. Neuropathol. Appl. Neurobiol. 16:1990;225-238.
16. Casar J.C., Cabello-Verrugio C., Olguin H., Aldunate R., Inestrosa N.C., Brandan E. Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation. J. Cell. Sci. 117:2004;73-84.
17. Chen X.D., Shi S., Xu T., Robey P.G., Young M.F. Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells. J. Bone Miner. Res. 17:2002;331-340.
18. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
19. Cohn R.D., Henry M.D., Michele D.E., Barresi R., Saito F., Moore S.A., Flanagan J.D., Skwarchuk M.W., Robbins M.E., Mendell J.R., Williamson R.A., Campbell K.P. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell. 110:2002;639-648.
20. Cornelison D.D., Wold B.J. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 191:1997;270-283.
21. Corsi A., Xu T., Chen X.D., Boyde A., Liang J., Mankani M., Sommer B., Iozzo R.V., Eichstetter I., Robey P.G., Bianco P., Young M.F. Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J. Bone Miner. Res. 17:2002;1180-1189.
22. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol. 136:1997;729-743.
23. De Luca A., Santra M., Baldi A., Giordano A., Iozzo R.V. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J. Biol. Chem. 271:1996;18961-18965.
24. Fisher L.W., Termine J.D., Young M.F. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J. Biol. Chem. 264:1989;4571-4576.
25. Fisher L.W., Stubbs J.T. III, Young M.F. Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop. Scand. (Suppl. 266):1995;61-65.
26. Fischer J.W., Kinsella M.G., Levkau B., Clowes A.W., Wight T.N. Retroviral overexpression of decorin differentially affects the response of arterial smooth muscle cells to growth factors. Arterioscler. Thromb. Vasc. Biol. 21:2001;777-784.
27. Grady R.M., Teng H., Nichol M.C., Cunningham J.C., Wilkinson R.S., Sanes J.R. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell. 90:1997;729-738.
28. Haslett J.N., Sanoudou D., Kho A.T., Bennett R.R., Greenberg S.A., Kohane I.S., Beggs A.H., Kunkel L.M. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 99:2002;15000-15005.
29. Henry S.P., Takanosu M., Boyd T.C., Mayne P.M., Eberspaecher H., Zhou W., de Crombrugghe B., Hook M., Mayne R. Expression pattern and gene characterization of asporin. A newly discovered member of the leucine-rich repeat protein family. J. Biol. Chem. 276:2001;12212-12221.
30. Hildebrand A., Romaris M., Rasmussen L.M., Heinegard D., Twardzik D.R., Border W.A., Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J. 302:1994;527-534.
31. Hocking A.M., Shinomura T., McQuillan D.J. Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol. 17:1998;1-19.
32. Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 67:1998;609-652.
33. Isaka Y., Brees D.K., Ikegaya K., Kaneda Y., Imai E., Noble N.A., Border W.A. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat. Med. 2:1996;418-423.
34. Ishii A., Lo S.H. A role of tensin in skeletal-muscle regeneration. Biochem. J. 356:2001;737-745.
35. Kolb M., Margetts P.J., Sime P.J., Gauldie J. Proteoglycans decorin and biglycan differentially modulate TGF-beta- mediated fibrotic responses in the lung. Am. J. Physiol., Lung Cell. Mol. Physiol. 280:2001;L1327-L1334.
36. Kresse H., Schonherr E. Proteoglycans of the extracellular matrix and growth control. J. Cell. Physiol. 189:2001;266-274.
37. Larrain J., Cizmeci-Smith G., Troncoso V., Stahl R.C., Carey D.J., Brandan E. Syndecan-1 expression is down-regulated during myoblast terminal differentiation. Modulation by growth factors and retinoic acid. J. Biol. Chem. 272:1997;18418-18424.
38. Larrain J., Carey D.J., Brandan E. Syndecan-1 expression inhibits myoblast terminal differentiation through a basic fibroblast growth factor-dependent mechanism. J. Biol. Chem. 273:1998;32288-32296.
39. Lorenzo P., Aspberg A., Onnerfjord P., Bayliss M.T., Neame P.J., Heinegard D. Identification and characterization of asporin. A novel member of the leucine-rich repeat protein family closely related to decorin and biglycan. J. Biol. Chem. 276:2001;12201-12211.
40. Lukashev M.E., Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol. 8:1998;437-441.
41. McLennan I.S., Koishi K. Cellular localisation of transforming growth factor-beta 2 and -beta 3 (TGF-beta2, TGF-beta3) in damaged and regenerating skeletal muscles. Dev. Dyn. 208:1997;278-289.
42. Melo F., Carey D.J., Brandan E. Extracellular matrix is required for skeletal muscle differentiation but not myogenin expression. J. Cell. Biochem. 62:1996;227-239.
43. Olguin H., Brandan E. Expression and localization of proteoglycans during limb myogenic activation. Dev. Dyn. 221:2001;106-115.
44. Osses N., Brandan E. ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression. Am. J. Physiol., Cell Physiol. 282:2001;C383-C394.
45. Pagel C.N., Partridge T.A. Covert persistence of mdx mouse myopathy is revealed by acute and chronic effects of irradiation. J. Neurol. Sci. 164:1999;103-116.
46. Porter J.D., Khanna S., Kaminski H.J., Rao J.S., Merriam A.P., Richmonds C.R., Leahy P., Li J., Guo W., Andrade F.H. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum. Mol. Genet. 11:2002;263-272.
47. Rafii M.S., Creely H.M.A.M., Ferri R.T., Seo N.S., Young M.F., McQuillan D.J., Fallon J.R. Interactions of the proteoglycan byglican with the dystrophin associated protein complex and its roles in muscular dystrophy and synaptogenesis. Mol. Biol. Cell. 11:2000;146a.
48. Rapraeger A., Bernfield M. Cell surface proteoglycan of mammary epithelial cells. Protease releases a heparan sulfate-rich ectodomain from a putative membrane- anchored domain. J. Biol. Chem. 260:1985;4103-4109.
49. Riquelme C., Larrain J., Schonherr E., Henriquez J.P., Kresse H., Brandan E. Antisense inhibition of decorin expression in myoblasts decreases cell responsiveness to transforming growth factor beta and accelerates skeletal muscle differentiation. J. Biol. Chem. 276:2001;3589-3596.
50. Sanes J.R. The basement membrane/basal lamina of skeletal muscle. J. Biol. Chem. 29:2003;29.
51. Santra M., Mann D.M., Mercer E.W., Skorski T., Calabretta B., Iozzo R.V. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J. Clin. Invest. 100:1997;149-157.
52. Santra M., Reed C.C., Iozzo R.V. Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope. J. Biol. Chem. 277:2002;35671-35681.
53. Seale P., Rudnicki M.A. A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev. Biol. 218:2000;115-124.
54. Silberstein L., Webster S.G., Travis M., Blau H.M. Developmental progression of myosin gene expression in cultured muscle cells. Cell. 46:1986;1075-1081.
55. Takeuchi Y., Kodama Y., Matsumoto T. Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. J. Biol. Chem. 269:1994;32634-32638.
56. Weiss A., Leinwand L.A. The mammalian myosin heavy chain gene family. Annu. Rev. Cell Dev. Biol. 12:1996;417-439.
57. Xu T., Bianco P., Fisher L.W., Longenecker G., Smith E., Goldstein S., Bonadio J., Boskey A., Heegaard A.M., Sommer B., Satomura K., Dominguez P., Zhao C., Kulkarni A.B., Robey P.G., Young M.F. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet. 20:1998;78-82.
58. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature. 270:1977;725-727.
59. Yamaguchi Y., Mann D.M., Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 346:1990;281-284.
60. Yan Z., Choi S., Liu X., Zhang M., Schageman J.J., Lee S.Y., Hart R., Lin L., Thurmond F.A., Williams R.S. Highly coordinated gene regulation in mouse skeletal muscle regeneration. J. Biol. Chem. 278:2003;8826-8836.